Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and Obesity (ObeApp)

December 19, 2025 updated by: Tarja Saaresranta, Turku University Hospital
The goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health approach, and 3) to compare differences in subjective sleep quality, diurnal eating pattern and gut microbiome at baseline 4) to compare changes induced by the E-health intervention among the three study groups and participants with different work schedules.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The data are fragmented and studies are focusing on interactions of sleep and obesity, eating pattern and obesity, or gut microbiota and obesity, but not the cross-talk of all these factors in the same individual or population. Therefore, we need a multifactorial approach to get a more deep insight on the obesity and weight regulation. Further, novel cost-effective tools to advance lifestyle changes are needed. Emerging evidence suggests that novel countermeasures, such as modulation of the timing of food intake, may be effective strategies in weight control and prevention of obesity. The goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health approach, and 3) to compare differences in subjective sleep quality, diurnal eating pattern and gut microbiome at baseline 4) to compare changes induced by the E-health intervention among the three study groups and participants with different work schedules.

Study Type

Interventional

Enrollment (Actual)

133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turku, Finland, 20521
        • Turku University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Community dwelling 18 - 65 year old adults
  • BMI 18.5 - 30 kg/m2 (n = 40, M:F = 1:1)
  • BMI > 30 kg/m2 (n = 40, M:F = 1:1)
  • OSAS patients with BMI > 30 kg/m2 using nasal continuous positive airway pressure (CPAP) treatment on an average > 4 h/d (n = 40, M:F = 1:1).

Exclusion Criteria:

  • Antimicrobial treatment within 3 months prior the baseline visit
  • Inflammatory bowel diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Lean-overweight
BMI 18.5 - 30 kg/m2
To compare changes induced by the movile app intervention among the three study groups
Active Comparator: Obese
BMI > 30 kg/m2
To compare changes induced by the movile app intervention among the three study groups
Active Comparator: Obese OSA
OSAS patients with BMI > 30 kg/m2
To compare changes induced by the movile app intervention among the three study groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 2 years
Changes in weight
2 years
Waist/Hip ratio
Time Frame: 2 years
Changes in Waist/Hip ratio
2 years
Change in Blood Pressure
Time Frame: 2 years
Change in Blood Pressure
2 years
GHbA1c
Time Frame: 2 years
Change in GHbA1c
2 years
Gut microbiota
Time Frame: 2 years
Changes in gut microbiota (species, proportions of different species)
2 years
Timing of eating
Time Frame: 2 years
Change in timing of eating
2 years
Subjective sleep quality (Pittsburg Sleep Quality Index)
Time Frame: 2 years
Changes in subjective sleep quality
2 years
Excessive daytime sleepiness (Epworth Sleepiness Scale)
Time Frame: 2 years
Change in excessive daytime sleepiness
2 years
Mood (DEPS questionnaire)
Time Frame: 2 years
Changes in mood
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tarja Saaresranta, MD, PhD, Turku University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

October 21, 2024

Study Completion (Actual)

October 21, 2024

Study Registration Dates

First Submitted

April 9, 2021

First Submitted That Met QC Criteria

April 14, 2021

First Posted (Actual)

April 20, 2021

Study Record Updates

Last Update Posted (Actual)

December 29, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Mobile app

Subscribe